NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of first-in-class carbohydrate-based therapeutic compounds, today reported its fourth quarter and full year 2006 financial results, ended December 31, 2006. The Company’s Annual Report on Form 10-K was filed with the Securities and Exchange Commission today.
